Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature

摘要

ImportanceBRAF inhibitors have been licensed for the therapy of BRAF-mutated melanoma. Recently, inflammatory skin lesions clinically resembling erythema nodosum have been reported as therapy side-effects that may lead to treatment discontinuation.